Search Orphan Drug Designations and Approvals
-
| Generic Name: | carglumic acid |
|---|---|
| Trade Name: | Carbaglu |
| Date Designated: | 01/20/1998 |
| Orphan Designation: | Treatment of N-acetylglutamate synthetase deficiency. |
| Orphan Designation Status: | Designated/Approved |
| Marketing Approval Date: | 03/18/2010 |
| Approved Labeled Indication: | As an adjunctive therapy for the treatment of acute hyperammonemia due to the deficiency of the hepatic enzyme N-acetylglutamate synthase (NAGS) and as manitenance therapy for chronic hyperammonemia due to NAGS deficiency |
| Exclusivity End Date: | 03/18/2017 |
| Exclusivity Protected Indication* : | |
| Sponsor: |
Orphan Europe SARL Immeuble Le Wilson 70 avenue du General de Gaulle Puteaux France The sponsor address listed is the last reported by the sponsor to OOPD. |
-
